Mixed Verdict on Boston Scientific Patents

(Natick, MA, USA) has announced that a jury in a patent infringement case involving the company's NIR stent, brought by Johnson & Johnson (J&J, New Brunswick, NJ, USA), has ruled in Boston Scientific's favor on three of the four patents at issue. The jury ruled in Boston Scientific's favor on five of the six claims at issue. The jury found that Boston Scientific infringed only one valid claim.

"We hope to persuade the judge to set aside the lone finding of infringement,” said Jim Tobin, president and CEO of Boston Scientific. "We will also present evidence in a separate hearing that these patents were improperly obtained by J&J and should therefore be unenforceable.”

The NIR stent with its multicellular design was developed and is manufactured by Medinol, Ltd. (Jerusalem, Israel). Boston Scientific has an exclusive worldwide license to market and distribute the NIR stent.



Related Links:
Boston Scientific